General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.
Asia Medical ×
Hong Kong Asia Medical Holding Limited is a leading privately-owned Chinese healthcare services provider and hospital operator specializing in cardiology.